[{"status": "Terminated", "city": "Allentown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92253", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "6580 Snowdrift Rd Ste 100", "address_2": "N/A", "postal_code": "18106-9331", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0670-2023", "product_description": "Cardioplegia Solution, Modified St Thomas Solution, HIGH POTASSIUM, HIGH SODIUM BICARBONATE, 106 mEq K, packaged in 1000 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA  18106, NDC 71285-0204-1.", "product_quantity": "241 bags", "reason_for_recall": "Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.", "recall_initiation_date": "20230428", "center_classification_date": "20230519", "termination_date": "20250622", "report_date": "20230531", "code_info": "Lot # 37-894705, Exp 04/30/2023; 37-896127, Exp 05/06/2023; 37-898278, Exp 05/14/2023; 37-899148, Exp 05/19/2023; 37-900619, Exp 05/25/2023"}, {"status": "Terminated", "city": "San Francisco", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "73662", "recalling_firm": "Reliable Rexall-A Compounding Pharmacy", "address_1": "801 Irving St", "address_2": "N/A", "postal_code": "94122-2310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S. Including: CA, HI, NM", "recall_number": "D-1078-2016", "product_description": "All fluocinonide Products, Rx Only, Compounded by RELIABLE DRUG/RELIABLE COMPOUNDING PHARMACY, 801 Irving St., SAN FRANCISCO, CA 94122.", "product_quantity": "N/A", "reason_for_recall": "Lack of Processing Controls", "recall_initiation_date": "20160325", "center_classification_date": "20160706", "termination_date": "20170410", "report_date": "20160713", "code_info": "All lots compounded between 03/24/2015 and 03/24/2016 and within expiry."}, {"country": "United States", "city": "Little Rock", "address_1": "1527 S Bowman Rd Ste D", "reason_for_recall": "Lack of Assurance of Sterility: Sterility of product is not assured.", "address_2": "", "product_quantity": "12 Bags", "code_info": "Compounded on 05/29/15, Discard After: 06/12/15", "center_classification_date": "20150701", "distribution_pattern": "United States including: Arkansas", "state": "AR", "product_description": "Vancomycin HCl in Dextrose, VANCOMYCIN 500mg / D5W 100mL AccuFlo, Qty: 12 100 mL Bags, Rx Only. Compounded by: United Medical IV Center (Little Rock) 1527 South Bowman Rd. Ste. D Little Rock, AR 72211-4200 501-227-0900.", "report_date": "20150708", "classification": "Class II", "openfda": {}, "recalling_firm": "Lincare, Inc.", "recall_number": "D-1167-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71415", "termination_date": "20170216", "more_code_info": "", "recall_initiation_date": "20150528", "postal_code": "72211-4200", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Athens", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83074", "recalling_firm": "RXQ Compounding LLC", "address_1": "340 W State St Unit 9", "address_2": "N/A", "postal_code": "45701-1564", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide USA", "recall_number": "D-1676-2019", "product_description": "MANGANESE SULFATE MONOHYDRATE (PFV) 0.1MG/ML INJ, 10 ML per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0952-10", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190619", "center_classification_date": "20190808", "termination_date": "20220916", "report_date": "20190814", "code_info": "All lots within expiry"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "134 units", "code_info": "Rx #'s:  0392321    0394025    0388514    0401919    0350642    0394025      0388514      0394025    0388514      0390732    0390733    0390734    0390735    0390736    0390737    0390738    0380350    0368327    0374556        0367241    0389528    0387672    0387673    0388017    0388019    0388022    0388506    0388512    0388515    0392608    0392615    0392616    0392619    0392621    0396198    0396215    0396216    0396229    0396231    0399438    0399439    0399442    0399445    0403009    0403010    0403011    0403012    0403013      0406259    0406260    0406262    0406344    0407979    0407983    0407994    0407995    0407997    0389528    0380350    0391097    0391097    0391097    0394711    0394711    0396280    0396282    0401229    0401451      0403261    0403264    0403265    0403266    0406344    0367241            0391097      0360638    0360913    0370332      0374556      0367241    0368572    0374556    0390415    0396119    0381037    0381037    0409349    0381037    0407487    0369244        0398000    0400203    0369244    0401228    0365406    0381433    0382639    0397201    0408640    0398000    0366257    0366257    0381433    0387899    0408486    0381433    0387899    0397201    0401228    0382639    0403456      0358087    0394872    0401833    0403472    0392320    0360357", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "INDOCYANINE GREEN - KIT 15MG INJECTABLE 1 KIT, 100 KIT, 12 KIT, 20 KIT,  50 KIT, 6 KIT, 75 KIT, 8 KIT; INDOCYANINE GREEN - KIT 1MG INJECTABLE 1 KIT, 10 `KIT, 10 KIT, 100 KIT, 18 VIAL, 2 KIT (51 DIFFERENT PRODUCTS)  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t2 VIAL  \t20 KIT  \t22 KITS  \t25 KITS  \t3 KITS  \t3 VIALS  \t4 VIALS  \t5 KIT  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t50 KIT  \t  \t  \t  \t  \t50 KITS  \t  \t6 KIT  \t  \t  \t  \t  \t  \t60 KIT  \t8 KIT  \t  INDOCYANINE GREEN - KIT 25MG INJECTABLE\t1 KIT  \t6 KIT  INDOCYANINE GREEN - KIT 30MG INJECTABLE\t10 KIT  \t14 KIT  \t25 KIT  \t5 KIT  INDOCYANINE GREEN - KIT 5MG INJECTABLE\t1 KIT  \t10 KIT  \t  \t  \t  \t  \t12 KIT  \t15 KIT  \t15 VIAL  \t2 KIT  \t  \t  \t20 KIT  \t25 KIT  \t3 KIT  \t4 KIT  \t  \t  \t  \t5 KIT  \t  \t  \t  \t6 KIT  \t  \t  \t8 KIT  INDOCYANINE GREEN, LYOPHILIZED 15MG VIAL\t1 VIAL  INDOCYANINE GREEN, LYOPHILIZED 1MG VIAL\t2 VIAL  \t5 VIAL  INDOCYANINE GREEN, LYOPHILIZED 5MG VIAL\t1 VIAL  \t2 KIT", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1546-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Rosenberg", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93986", "recalling_firm": "Seatex LLC", "address_1": "445 Highway 36 N", "address_2": "", "postal_code": "77471-8756", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the US and Puerto Rico", "recall_number": "D-0360-2024", "product_description": "PROBLEND Hand Sanitizer, Refreshing Gel Hand Sanitizer, Ethanol 70% v/v Antiseptic, mountain spring scent, 1250 mL cases, Seatex LLC, 445 TX Hwy 36 Rosenberg, YX 77471", "product_quantity": "480 cases", "reason_for_recall": "CGMP Deviations: deficiencies were identified during an FDA inspection of Seatex's manufacturing facility.", "recall_initiation_date": "20240219", "center_classification_date": "20240229", "termination_date": "20250815", "report_date": "20240306", "code_info": "Lot #: 266029, Exp. 03/27/2024.", "more_code_info": ""}, {"status": "Ongoing", "city": "Miami", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021514"], "brand_name": ["DAYTRANA"], "generic_name": ["METHYLPHENIDATE"], "manufacturer_name": ["Noven Therapeutics, LLC"], "product_ndc": ["68968-5552", "68968-5553", "68968-5554", "68968-5555"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TRANSDERMAL"], "substance_name": ["METHYLPHENIDATE"], "rxcui": ["753436", "753437", "753438", "753439", "753440", "753441", "753442", "753443"], "spl_id": ["55f4b5f4-6d3c-4677-a94c-d47ffb59a91a"], "spl_set_id": ["2c312c31-3198-4775-91ab-294e0b4b9e7f"], "package_ndc": ["68968-5552-3", "68968-5553-3", "68968-5554-3", "68968-5555-3"], "is_original_packager": [true], "nui": ["N0000175739", "N0000175729"], "pharm_class_epc": ["Central Nervous System Stimulant [EPC]"], "pharm_class_pe": ["Central Nervous System Stimulation [PE]"], "unii": ["207ZZ9QZ49"]}, "product_type": "Drugs", "event_id": "91882", "recalling_firm": "Noven Pharmaceuticals Inc", "address_1": "11960 Sw 144th St", "address_2": "N/A", "postal_code": "33186-6109", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US Nationwide", "recall_number": "D-0473-2023", "product_description": "Daytrana (methylphenidate transdermal system) CII, 30 mg, 30-count carton, Rx only, Manufactured for Noven Therapeutics, LLC., Miami by Noven Pharmaceuticals, Inc., NDC 68968-5555-3", "product_quantity": "N/A", "reason_for_recall": "Defective Delivery System: Out of specification for shear.", "recall_initiation_date": "20230310", "center_classification_date": "20230320", "report_date": "20230329", "code_info": "Lot#: 91474, 91959, Exp. 3/2023; 91958, Exp. 6/2023; 92478, Exp. 7/2023; 92479 & 92198, Exp. 8/2023; 92199, 93040, Exp. 9/2023; 93041, Exp. 10/2023."}, {"status": "Ongoing", "city": "Saint Louis", "state": "MO", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M018"], "brand_name": ["ARTIFICIAL TEARS"], "generic_name": ["ARTIFICIAL TEARS"], "manufacturer_name": ["AvPAK"], "product_ndc": ["50268-043"], "product_type": ["HUMAN OTC DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["DEXTRAN 70", "GLYCERIN", "HYPROMELLOSES"], "rxcui": ["900138"], "spl_id": ["334b4087-9641-b765-e063-6394a90a28a6"], "spl_set_id": ["f18bebf2-1936-658f-e053-2a95a90a5012"], "package_ndc": ["50268-043-15"], "is_original_packager": [true], "nui": ["N0000184175", "N0000009361", "N0000010288", "N0000185370", "N0000175629", "N0000184306", "N0000185001", "M0000728", "M0009417"], "pharm_class_epc": ["Plasma Volume Expander [EPC]", "Non-Standardized Chemical Allergen [EPC]"], "pharm_class_pe": ["Increased Intravascular Volume [PE]", "Increased Histamine Release [PE]", "Cell-mediated Immunity [PE]", "Increased IgG Production [PE]"], "pharm_class_moa": ["Osmotic Activity [MoA]"], "pharm_class_cs": ["Allergens [CS]", "Glycerol [CS]"], "unii": ["7SA290YK68", "PDC6A3C0OX", "3NXW29V3WO"]}, "product_type": "Drugs", "event_id": "96741", "recalling_firm": "BRS Analytical Services, LLC", "address_1": "11697 Lakeside Crossing Ct", "address_2": "N/A", "postal_code": "63146-8606", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0404-2025", "product_description": "Artificial Tears Ophthalmic Solution, Dextran 70.01%/Glycerin 0.2%/Hypromellose 0.3% (Eye Lubricants) Lubricant Eye Drops, STERILE, 0.5 FL OZ (15 mL) per dropper bottle, Distributed by: AvKARE, Pulaski, TN 38478, NDC: 50268-043-15.", "product_quantity": "13,872 cases (24 cartons per case)", "reason_for_recall": "cGMP deviations and lack of assurance of sterility.", "recall_initiation_date": "20250423", "center_classification_date": "20250506", "report_date": "20250514", "code_info": "Lot, expiry:  Lot 126, exp 10/26/25; Lot 127, exp 10/30/25; Lot 128, exp 11/02/25; Lot 129, exp 11/06/25; Lot 162, exp 5/09/26; Lot 163, exp 5/14/26; Lot 164, exp 5/20/26; Lot 165, exp 5/23/26; Lot 166, exp 5/29/26; Lot 167, exp 6/03/26; Lot 168, exp 6/06/26; Lot 169, exp 6/10/26; Lot 170, exp 6/13/26; Lot 193, exp 10/07/26; Lot 194, exp 10/10/26; Lot 195, exp 10/14/26; Lot 196, exp 10/17/26; Lot 197, exp 10/21/26; Lot 198, exp 10/24/26; Lot 199, exp 10/30/26.", "more_code_info": ""}, {"status": "Terminated", "city": "Rockford", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89930", "recalling_firm": "Mylan Institutional, Inc. (d.b.a. UDL Laboratories)", "address_1": "1718 Northrock Ct", "address_2": "N/A", "postal_code": "61103-1201", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within USA", "recall_number": "D-0860-2022", "product_description": "Esomeprazole Magnesium Delayed-Release Capsules, USP 20 mg, packaged in Unit Dose Blister Cards of 6 (10 cards of 6 Capsules each per carton), Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA. NDC 42292-009-16", "product_quantity": "555 cartons", "reason_for_recall": "Failed Impurities/Degradation Specifications: OOS result was obtained for Any Other Individual Impurity at the 12M room temperature time point.", "recall_initiation_date": "20220401", "center_classification_date": "20220511", "termination_date": "20230609", "report_date": "20220518", "code_info": "Lot #: 3112743, Exp. Date 4/30/2023; 3112582, Exp. Date 3/31/2023; 3110438, 3111708, 3111120, Exp. Date 7/31/2022"}, {"status": "Terminated", "city": "San Francisco", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "73662", "recalling_firm": "Reliable Rexall-A Compounding Pharmacy", "address_1": "801 Irving St", "address_2": "N/A", "postal_code": "94122-2310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S. Including: CA, HI, NM", "recall_number": "D-1075-2016", "product_description": "All monobenzone Products, Rx Only, Compounded by RELIABLE DRUG/RELIABLE COMPOUNDING PHARMACY, 801 Irving St., SAN FRANCISCO, CA 94122.", "product_quantity": "N/A", "reason_for_recall": "Lack of Processing Controls", "recall_initiation_date": "20160325", "center_classification_date": "20160706", "termination_date": "20170410", "report_date": "20160713", "code_info": "All lots compounded between 03/24/2015 and 03/24/2016 and within expiry."}, {"status": "Terminated", "city": "Miami Lakes", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83190", "recalling_firm": "Pharma-Natural Inc.", "address_1": "14500 Nw 60th Ave Bldg 7f", "address_2": "N/A", "postal_code": "33014", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Consignees in FL and TX who may have further distributed Nationwide in the USA and Puerto Rico.", "recall_number": "D-1496-2019", "product_description": "ARMY HEALTH Pain Reliever Gel With CURCUMIN (Menthol 3.00%), 0.5 OZ jar, Manufactured exclusively for: Manufactured exclusively for: Crossover Telecom, LLC., P.O. Box 520248, Miami, FL 33122, UPC 8 50993 00461 1.", "product_quantity": "1508 jars", "reason_for_recall": "CGMP Deviations: products were manufactured with lack of process validation, cleaning validation, stability studies, and other current good manufacturing practice violations.", "recall_initiation_date": "20190621", "center_classification_date": "20190723", "termination_date": "20211027", "report_date": "20190731", "code_info": "All lots remaining within expiry."}, {"country": "United States", "city": "Noblesville", "address_1": "14450 Getz Rd", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "30", "code_info": "All Sterile Compounded Products within Expiry", "center_classification_date": "20160711", "distribution_pattern": "Nationwide        VA/DOD: CA, KY, MD, NC, OK, TX, VA", "state": "IN", "product_description": "Morphine Sulfate (Preserved) 2mg/mL in 0.9% Sodium Chloride 50 mL fill in a 60 ml BD Syringe, Rx Only, Compounded by PHARMAKON Pharmaceuticals, Noblesville, IN 46060, NDC 45183-0823-75", "report_date": "20160720", "classification": "Class II", "openfda": {}, "recalling_firm": "Pharmakon Pharmaceuticals, Inc.", "recall_number": "D-1307-2016", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "73960", "termination_date": "20180111", "more_code_info": "", "recall_initiation_date": "20160420", "postal_code": "46060-3303", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96308", "recalling_firm": "Safecor Health, LLC", "address_1": "4060 Business Park Dr Ste B", "address_2": "", "postal_code": "43204-5047", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0250-2025", "product_description": "Ergocalciferol - Vitamin D Supplement - 10 mcg (400 Units) per 0.05 mL Oral Syringe, Delivers: 0.05 mL Oral Solution, Mfg by: Westminster, Pkg by: Safecor Health, LLC, Columbus, OH 43204, NDC: 69367028302.", "product_quantity": "3069 Oral Syringes", "reason_for_recall": "Defective Delivery System: Leakage observed after oral solution was repackaged into unit-dose syringes.", "recall_initiation_date": "20250217", "center_classification_date": "20250305", "report_date": "20250312", "code_info": "Lot #:  24300812, Exp 01/31/2025; 24530836, Exp 07/19/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "94265", "recalling_firm": "Pyramids Wholesale Inc.", "address_1": "464 E 4th St", "address_2": "N/A", "postal_code": "90013-1604", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0452-2024", "product_description": "Pink Pussycat Honey, net wt:  20gx12 sachets, UPC 7 918750 046557", "product_quantity": "149 boxes", "reason_for_recall": "Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.", "recall_initiation_date": "20240319", "center_classification_date": "20240422", "report_date": "20240501", "code_info": "All Lots", "more_code_info": ""}, {"status": "Terminated", "city": "Mesa", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83669", "recalling_firm": "First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy", "address_1": "6828 E Brown Rd Ste 101", "address_2": "N/A", "postal_code": "85207-3761", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0271-2020", "product_description": "S-METHYLCOBALAMIN 10,000MCG/ML MDV INJ; 30ML glass vial, Rx Only, Red Mountain Compounding Rx", "product_quantity": "135x30 ml glass vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190812", "center_classification_date": "20191105", "termination_date": "20230413", "report_date": "20191113", "code_info": "Lot #:  S05162019DH@12, Exp 8/16/19; S05282019DT@06, Exp 8/28/19;  S05302019DT@05, Exp 8/30/19; S06182019DT@03, Exp 9/18/19;  S07102019dt@05, Exp 10/10/19;  S07162019DT@08, Exp 10/16/19; S07242019DH@02, Exp 10/24/19; S07252019DH@08, Exp 10/25/19;   S06242019DH@01, Exp 9/24/19; S07032019DT@10, EXP 10/03/2019, S07102019DT@05, Exp 10/10/2019, 07242019DH@02, Exp 10/24/19; S07252019DH@08, Exp 10/25/2019, S07292019DH@15, Exp 10/29/19;"}, {"status": "Ongoing", "city": "Dabhel, Daman", "state": "", "country": "India", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "97766", "recalling_firm": "USV Private Limited", "address_1": "H-13, 16, 16a, 17, 18, 19, 20, 21 & E-22, Oidc, Mahatma Gandhi Udyog Nagar", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0034-2026", "product_description": "Olopatadine Hydrochloride Ophthalmic Solution USP 0.1 %, 5 mL (0.17 FL OZ) bottles, Manufactured for: SOLA PHARMACEUTICALS LLC, Baton Rouge, LA 70810, NDC 70512-0520-05", "product_quantity": "8,952 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications: The result for 'Any individual unspecified impurity' exceeds the specification limit.", "recall_initiation_date": "20251009", "center_classification_date": "20251020", "report_date": "20251029", "code_info": "Lot #:  35000409, Exp. Date 01/2026", "more_code_info": ""}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84798", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "400 Interpace Pkwy", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0830-2020", "product_description": "Desmopressin Acetate Tablets, 0.1 mg, 100-count bottle, Rx Only, Manufactured by: Actavis Laboratories, Inc. Fort Lauderdale, FL 33314 USA, Distributed by: Actavis Pharma, Inc. Parisppany, NJ 07054 USA, NDC 0591-2464-01", "product_quantity": "22,868 bottles", "reason_for_recall": "GMP Deviations: Product bottle may be absent of desiccant.", "recall_initiation_date": "20200127", "center_classification_date": "20200206", "termination_date": "20201210", "report_date": "20200212", "code_info": "Lot #: 1281203M, exp. date 03/2020 and 1290113M, exp. date 04/2020"}, {"status": "Completed", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91466", "recalling_firm": "Sentara Infusion Services", "address_1": "535 Independence Pkwy Ste 300", "address_2": "N/A", "postal_code": "23320-5176", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Dispensed to Patients Nationwide.", "recall_number": "D-0295-2023", "product_description": "HYDROCORTISONE 9a) 2MG IN NS 0.2ML SYRINGE, 9MG IN NS 2ML SYRINGE, steroid, Rx Only, Sentara Home Infusion Pharmacy Services, 535 Independence Pkwy, Ste 300, Chesapeake, VA 23320, NDC#  00009-0011-04", "product_quantity": "32 syringes", "reason_for_recall": "Lack of sterility assurance", "recall_initiation_date": "20221227", "center_classification_date": "20230215", "report_date": "20230222", "code_info": "Beyond Use Date: December 24-31, 2022"}, {"status": "Terminated", "city": "Henderson", "state": "NV", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80343", "recalling_firm": "Gaia Ethnobotanical LLC", "address_1": "2752 Botticelli Dr", "address_2": "", "postal_code": "89052-3107", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide.", "recall_number": "D-1016-2018", "product_description": "Gaia Kratom (mitragyna speciosa) powder, Yellow Vietnam, 1oz, 250g, 1kg packages, Gaia Ethnobotanical.com", "product_quantity": "unknown", "reason_for_recall": "Microbal Contamination of Non-Sterile Product; FDA analysis found  salmonella contamination", "recall_initiation_date": "20180620", "center_classification_date": "20180726", "termination_date": "20220126", "report_date": "20180718", "code_info": "Lot # 0102031800", "more_code_info": ""}, {"status": "Ongoing", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA209755"], "brand_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "generic_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "manufacturer_name": ["American Health Packaging"], "product_ndc": ["60687-419", "60687-430", "60687-441", "60687-452", "60687-463"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "rxcui": ["991039", "991044", "991188", "991194", "991336"], "spl_id": ["19336340-ad22-62b7-e063-6294a90affed"], "spl_set_id": ["d43718e5-66d7-44f9-9fc8-80d38d3e41ce"], "package_ndc": ["60687-419-11", "60687-419-01", "60687-430-11", "60687-430-01", "60687-430-65", "60687-441-11", "60687-441-01", "60687-452-11", "60687-452-01", "60687-463-11", "60687-463-01"], "original_packager_product_ndc": ["69238-1054", "69238-1056", "69238-1058", "69238-1060", "69238-1062"], "unii": ["9WP59609J6"]}, "product_type": "Drugs", "event_id": "97533", "recalling_firm": "Amerisource Health Services LLC", "address_1": "2550 John Glenn Ave Ste A", "address_2": "N/A", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0648-2025", "product_description": "chlorproMAZINE Hydrochloride Tablets, USP, 50 mg, 100 (10x10) blisterpacks, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217. 50 Tablet Carton NDC#: 60687-441-01 (Individual Dose NDC: 60687-441-11)", "product_quantity": "1,062 cartons", "reason_for_recall": "Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging at the manufacturing site, was detected with presence of a micro-organism. No micro-organism was detected on any tablets.", "recall_initiation_date": "20250827", "center_classification_date": "20250915", "report_date": "20250924", "code_info": "Lot: 1022159, exp 12/31/2026; 1023299, exp 03/31/2027; 1024057, Exp 04/30/2027"}, {"country": "United States", "city": "Columbus", "address_1": "2550 John Glenn Ave Ste A", "reason_for_recall": "Labeling: Label Mix-Up: A typographical error in the product form on the carton label incorrectly lists the configuration as 30 \"Capsules\" (3 x 10) rather than \"Tablets\".", "address_2": "", "product_quantity": "1,170 cartons", "code_info": "Lot #: 113032A, 113032B, Exp 04/13", "center_classification_date": "20120814", "distribution_pattern": "Nationwide", "state": "OH", "product_description": "Topiramate Tablets, 50 mg, 30-count (3 x 10) unit-dose blisters per carton, Rx only, Mfd by: Cadila Healthcare Ltd., Ahmedabad, India; Dist By: Zydus Pharmaceuticals USA, Inc., Pennington, NJ 08534, Pkg by: American Health Packaging, Col. OH 43217, NDC 68084-343-21, blister barcode 6808434311", "report_date": "20120822", "classification": "Class III", "openfda": {}, "recalling_firm": "American Health Packaging", "recall_number": "D-1645-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62792", "termination_date": "20130702", "more_code_info": "", "recall_initiation_date": "20120725", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0656-2019", "product_description": "Dr. King's Natural Medicine Homeopathic Odor Freee, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Dr. Asheville, NC 28806, UPC 357955513025, NDC 57955-5130-2", "product_quantity": "283 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 102816H Exp. 10/2019; 123016D Exp. 12/2019"}, {"status": "Ongoing", "city": "Dallas", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "94354", "recalling_firm": "ARG Laboratories, Inc.", "address_1": "2639 Manana Dr", "address_2": "", "postal_code": "75220-1301", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0526-2024", "product_description": "NATURAL PAIN RELIEVING CREAM, GOLDEN TIGER, (Camphor 3%, Menthol 3%)Enriched with Pump Capsaicin, Aloe Vera, Willow Bark & MSM, Bottle with Pump NET WT 32 fl. oz (946.33ml), Manufactured for Golden Tiger LLC Made in USA, UPC 1 82294 00004 8", "product_quantity": "500", "reason_for_recall": "Out of Specification for active ingredient. Violative grade of propylene glycol used during the manufacturing process.", "recall_initiation_date": "20240417", "center_classification_date": "20240530", "report_date": "20240605", "code_info": "Lot 01823C2, 01823C1, Exp 01/31/2025", "more_code_info": ""}, {"status": "Terminated", "city": "Greenville", "state": "SC", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA203621"], "brand_name": ["NYSTATIN"], "generic_name": ["NYSTATIN"], "manufacturer_name": ["Pharmaceutical Associates, Inc."], "product_ndc": ["0121-0810", "0121-4810"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["NYSTATIN"], "rxcui": ["312055"], "spl_id": ["d57cde69-0eb9-180d-e053-2995a90a33aa"], "spl_set_id": ["31e3da10-5a7b-4bc5-8a4f-3e786b64c13a"], "package_ndc": ["0121-0810-02", "0121-0810-16", "0121-4810-05", "0121-4810-40", "0121-4810-00", "0121-4810-50"], "is_original_packager": [true], "upc": ["0301210810022"], "nui": ["N0000175498", "M0017172"], "pharm_class_epc": ["Polyene Antifungal [EPC]"], "pharm_class_cs": ["Polyenes [CS]"], "unii": ["BDF1O1C72E"]}, "product_type": "Drugs", "event_id": "86170", "recalling_firm": "PAI Holdings, LLC. dba Pharmaceutical Associates Inc", "address_1": "1700 Perimeter Rd", "address_2": "N/A", "postal_code": "29605-5252", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-1494-2020", "product_description": "Nystatin Oral Suspension, USP 100,000 units per mL, Cherry/Peppermint Flavor, 16 fl. oz. (473 mL), Rx only, Pharmaceutical Associates, Inc. Greenville, SC 29605, NDC 0121-0810-16", "product_quantity": "7416 bottles", "reason_for_recall": "Subpotent drug: Out of specification for assay at the 15-month test interval.", "recall_initiation_date": "20200804", "center_classification_date": "20200812", "termination_date": "20210922", "report_date": "20200819", "code_info": "Lot: B973, Exp 11/20"}, {"status": "Terminated", "city": "New York", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA020125"], "brand_name": ["ACCURETIC"], "generic_name": ["QUINAPRIL AND HYDROCHLOROTHIAZIDE"], "manufacturer_name": ["Parke-Davis Div of Pfizer Inc"], "product_ndc": ["0071-3112", "0071-0223", "0071-5212", "0071-7225"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["HYDROCHLOROTHIAZIDE", "QUINAPRIL HYDROCHLORIDE"], "rxcui": ["310796", "310797", "310809", "809854", "809858", "882559"], "spl_id": ["489727cb-429e-4f04-a973-ae4dc7898519"], "spl_set_id": ["80e9d61d-9674-4ac4-b84c-79a875d408dd"], "package_ndc": ["0071-0223-23", "0071-3112-23", "0071-5212-23", "0071-7225-23"], "is_original_packager": [true], "upc": ["0300717225230", "0300713112237", "0300710223233", "0300715212232"], "nui": ["N0000175359", "N0000175419", "M0471776"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]"], "pharm_class_cs": ["Thiazides [CS]"], "unii": ["0J48LPH2TH", "33067B3N2M"]}, "product_type": "Drugs", "event_id": "89864", "recalling_firm": "Pfizer Inc.", "address_1": "235 East 42nd Street", "address_2": "", "postal_code": "10017-5703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0761-2022", "product_description": "Accuretic (quinapril HCl/hydrochlorothiazide) tablets, 20 mg/12.5 mg*, 90 Tablets, Rx Only, Distributed by: Parke-Davis, Division of Pfizer Inc., NY. NY 10017, Made in Germany,  NDC 0071-5212-23    .", "product_quantity": "195 bottles", "reason_for_recall": "CGMP Deviations: N-nitroso-quinapril and N-nitroso-hydrochlorothiazide impurity above the acceptable daily intake limit.", "recall_initiation_date": "20220321", "center_classification_date": "20220406", "termination_date": "20240828", "report_date": "20220413", "code_info": "Lot FG5381; Exp. 08/2024", "more_code_info": ""}, {"status": "Ongoing", "city": "Woburn", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M343"], "brand_name": ["ASPIRIN"], "generic_name": ["ASPIRIN 81 MG"], "manufacturer_name": ["Safecor Health, LLC"], "product_ndc": ["48433-129"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["ASPIRIN"], "rxcui": ["318272"], "spl_id": ["2a9cbf5e-9081-4b19-bd60-5ddf103a0133"], "spl_set_id": ["b499f378-db7c-464e-bee3-eb23f8fdaced"], "package_ndc": ["48433-129-01"], "original_packager_product_ndc": ["69168-288"], "nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "unii": ["R16CO5Y76E"]}, "product_type": "Drugs", "event_id": "95659", "recalling_firm": "Safecor Health, LLC", "address_1": "317 New Boston St", "address_2": "N/A", "postal_code": "01801-6231", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-0058-2025", "product_description": "Aspirin Chewable tablet 81 mg, 1 tablet in blister card-foils, 100-count unit dose box, www.safecorhealth.com, NDC 48433-129-01", "product_quantity": "1470 boxes", "reason_for_recall": "cGMP Deviations: Observations were made that some blister card-foils were separating from the blister cavity.", "recall_initiation_date": "20241111", "center_classification_date": "20241119", "report_date": "20241127", "code_info": "Lot# 24A0061, exp. date 05/23/2026"}, {"status": "Terminated", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88591", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-0824-2021", "product_description": "Chlorzoxazone Tablets USP 750 mg 100 Tablets Rx Only NDC 68462-725-01  Manufactured by: Glenmark Pharmaceuticals Inc., USA 4147 Goldmine Road Monroe, NC 28110 Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430", "product_quantity": "4752 bottles", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20210827", "center_classification_date": "20210921", "termination_date": "20231004", "report_date": "20210929", "code_info": "Lots: 29200023 Exp. 03/31/2022; 29200025 Exp. 03/31/2022; 29200036 Exp. 06/30/2022; 29200056 Exp. 09/30/2022; 29200070 Exp. 11/30/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Indiana", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "76457", "recalling_firm": "RemedyRepack Inc.", "address_1": "625 Kolter Dr Ste 4", "address_2": "N/A", "postal_code": "15701-3571", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to  a sold customer in FL.", "recall_number": "D-0482-2017", "product_description": "Glipizide 2.5 mg ER Tablets, Manufactured by Watson Laboratories, Inc., Parsippany, NJ 07054, Repackaged by RemedyRepack, Indiana, PA 15701, NDC 52125-0764-02", "product_quantity": "630 pills (21 bottles x 30 pills per HDPE bottle)", "reason_for_recall": "Failed Dissolution Specifications", "recall_initiation_date": "20170207", "center_classification_date": "20170218", "termination_date": "20170505", "report_date": "20170301", "code_info": "Lot #  B0129373-021916; Exp. 10/17    00591-0900-30  Original NDC  52125-0764-02  RemedyRepack NDC"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-912-2015", "product_description": "Tadalafil Citrate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "3684 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Earth City", "state": "MO", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA022525"], "brand_name": ["NAMENDA"], "generic_name": ["MEMANTINE HYDROCHLORIDE"], "manufacturer_name": ["Allergan, Inc."], "product_ndc": ["0456-3428", "0456-3407", "0456-3414", "0456-3421", "0456-3400"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["MEMANTINE HYDROCHLORIDE"], "rxcui": ["996594", "996597", "996603", "996605", "996609", "996611", "996615", "996617", "996624", "996633"], "spl_id": ["59743420-cc2e-4578-9420-513694a3972d"], "spl_set_id": ["710f523f-0158-4639-8ce7-57598247d48c"], "package_ndc": ["0456-3407-33", "0456-3414-33", "0456-3414-90", "0456-3414-11", "0456-3414-63", "0456-3421-33", "0456-3428-33", "0456-3428-90", "0456-3428-11", "0456-3428-63", "0456-3400-29"], "is_original_packager": [true], "unii": ["JY0WD0UA60"]}, "product_type": "Drugs", "event_id": "66838", "recalling_firm": "Forest Pharmaceuticals Inc", "address_1": "13600 Shoreline Dr", "address_2": "", "postal_code": "63045", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico.", "recall_number": "D-1063-2014", "product_description": "Namenda XR (memantine HCl), 7 mg extended release capsules, 30-count bottle, Rx only, Forest Pharmaceuticals Inc., St. Louis, MO 63045, NDC 0456-3407-33", "product_quantity": "156 bottles", "reason_for_recall": "Failed Dissolution Specifications: Three lots of product being recalled having failed stability dissolution testing.", "recall_initiation_date": "20131113", "center_classification_date": "20140204", "termination_date": "20140507", "report_date": "20140212", "code_info": "Lot 1111291 Exp. 02/16", "more_code_info": ""}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0596-2019", "product_description": "Dr. King's Natural Medicine Homeopathic Sore Throat & Laryngitis, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Dr. Asheville, NC 28806, UPC 357955505822, NDC 57955-5058-2", "product_quantity": "6028 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 010118AH Exp. 01/20; 020916R Exp. 02/19; 022017B Exp. 02/20; 080415E Exp. 08/18; 090816F Exp. 09/19"}, {"status": "Terminated", "city": "Buena", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89798", "recalling_firm": "Teligent Pharma, Inc.", "address_1": "105 Lincoln Avenue", "address_2": "N/A", "postal_code": "08310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0689-2022", "product_description": "Halobetasol Propionate Ointment, 0.05%, packaged as a) 15 g tubes, NDC 52565-073-15; b) 50 g tubes, NDC 52565-073-51, Rx Only, Manufactured by: Teligent Pharma, Inc., Buena, NJ 08310.", "product_quantity": "161,331 tubes", "reason_for_recall": "cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.", "recall_initiation_date": "20220315", "center_classification_date": "20220321", "termination_date": "20240617", "report_date": "20220330", "code_info": "Batch: a) 15280, Exp. 2/28/2022; 16539, Exp. 3/31/2023; 16907, Exp. 5/31/2023; b) 15381, Exp. 3/31/2022; 15382, 15501, 15523, Exp. 4/30/2022; 15812, Exp. 7/31/2022; 15972, 16034, 16037, Exp. 9/30/2022; 16105, 16143, Exp. 10/31/2022; 16539, 16746, 16747, Exp. 3/31/2023; 16906, Exp. 5/31/2023; 16962, 17041, Exp. 6/30/2023; 17110, Exp. 7/31/2023"}, {"status": "Terminated", "city": "Miami", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021514"], "brand_name": ["DAYTRANA"], "generic_name": ["METHYLPHENIDATE"], "manufacturer_name": ["Noven Therapeutics, LLC"], "product_ndc": ["68968-5552", "68968-5553", "68968-5554", "68968-5555"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TRANSDERMAL"], "substance_name": ["METHYLPHENIDATE"], "rxcui": ["753436", "753437", "753438", "753439", "753440", "753441", "753442", "753443"], "spl_id": ["55f4b5f4-6d3c-4677-a94c-d47ffb59a91a"], "spl_set_id": ["2c312c31-3198-4775-91ab-294e0b4b9e7f"], "package_ndc": ["68968-5552-3", "68968-5553-3", "68968-5554-3", "68968-5555-3"], "is_original_packager": [true], "nui": ["N0000175739", "N0000175729"], "pharm_class_epc": ["Central Nervous System Stimulant [EPC]"], "pharm_class_pe": ["Central Nervous System Stimulation [PE]"], "unii": ["207ZZ9QZ49"]}, "product_type": "Drugs", "event_id": "69277", "recalling_firm": "Noven Pharmaceuticals, Inc.", "address_1": "11960 Sw 144th St", "address_2": "N/A", "postal_code": "33186-6109", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-1608-2014", "product_description": "Daytrana (methylphenidate transdermal system) patch, Delivers 20 mg over 9 hours (2.2mg/hr), 1 patch per pouch , packaged in 30-count patches per box, Rx Only. Manufactured for Noven Therapeutics, LLC, Miami, FL 33186, By Noven Pharmaceuticals, Inc., Miami, FL 33186.  NDC 68968-5554-3.", "product_quantity": "160,800 patches", "reason_for_recall": "Defective Delivery System: Out of Specification (OOS) results for the mechanical peel force (MPF) and z-statistic value which relates to the patients and caregiver ability to remove the release liner from the patch adhesive prior to administration.", "recall_initiation_date": "20140715", "center_classification_date": "20140923", "termination_date": "20190319", "report_date": "20141001", "code_info": "Lot # 71165; Exp. 12/14"}, {"status": "Terminated", "city": "Miami", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85926", "recalling_firm": "WORLD EVENT PROMOTIONS, LLC", "address_1": "4300 Sw 73rd Ave Ste 110", "address_2": "N/A", "postal_code": "33155-4529", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-1411-2020", "product_description": "Handese Advanced Instant Hand Sanitizer (Ethyl Alcohol 70%), 12 FL OZ (354 mL) bottles,  www.handeseclean.com UPC 612520481094", "product_quantity": "14050 bottles", "reason_for_recall": "Subpotent Drug: Product was found to be subpotent. Product also has high pH levels", "recall_initiation_date": "20200601", "center_classification_date": "20200728", "termination_date": "20230517", "report_date": "20200805", "code_info": "All Lots"}, {"status": "Terminated", "city": "Ocala", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75289", "recalling_firm": "Wells Pharmacy Network LLC", "address_1": "1210 SW 33rd Ave", "address_2": "N/A", "postal_code": "34474-2853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0375-2017", "product_description": "MIC/Chromium/B12(M) Injectable, 25 mg/50 mg/50 mg/25 mcg/1 mg/mL, 10 mL vial, Compounded by Wells Pharmacy, Ocala, FL", "product_quantity": "648 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20160921", "center_classification_date": "20170104", "termination_date": "20210702", "report_date": "20170111", "code_info": "All lot codes of product prepared between 02/22/2016 and 09/14/2016, within expiry.     Known lot code: 03302016@8, 04152016@5, 05032016@15, 05262016@24, 06142016@1, 07202016@55."}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82615", "recalling_firm": "Customceutical Compounding", "address_1": "4611 E Shea Blvd Bldg 3 Ste 180", "address_2": "N/A", "postal_code": "85028-4258", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-1258-2019", "product_description": "Test D (TESTOSTERONE CYPIONATE 200MG/ML VITAMIN D3 5,000IU/ML), 5 ML MULTIDOSE VIAL COMPOUNDED.  Customceutical Compounding 4611 E. Shea Blvd. Bldg 3 180, Phoenix, AZ 85028 Ph. 480 516 0272", "product_quantity": "8 vials", "reason_for_recall": "Lack of assurance of sterility for injectables and solutions intended to be sterile.", "recall_initiation_date": "20190408", "center_classification_date": "20190430", "termination_date": "20230519", "report_date": "20190508", "code_info": "Lot #: 01232019@25, Exp 4/23/19"}, {"country": "United States", "city": "Orlando", "address_1": "6700 Conroy Windermere Rd", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes", "address_2": "Suite 140", "product_quantity": "1", "code_info": "B5125 Exp 8/25/13", "center_classification_date": "20130711", "distribution_pattern": "Nationwide and PR", "state": "FL", "product_description": "Gentamicin Sulfate 80 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL", "report_date": "20130717", "classification": "Class II", "openfda": {}, "recalling_firm": "Lowlite Investments, Inc. D/B/A Olympia Pharmacy", "recall_number": "D-735-2013", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "65360", "recall_initiation_date": "20130529", "postal_code": "32835-3500", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Ongoing"}, {"status": "Terminated", "city": "Wilsonville", "state": "OR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69519", "recalling_firm": "Oregon Compounding Centers, Inc. dba Creative Compounds", "address_1": "8560 Sw Salish Ln Ste 100", "address_2": "N/A", "postal_code": "97070-9625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Oregon, Washington", "recall_number": "D-0196-2015", "product_description": "GLUTATHIONE, 100 mg/mL, injectable, 100 mL glass vial, RX, Creative Compounds, Wilsonville, OR 97070", "product_quantity": "900 mL", "reason_for_recall": "Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.", "recall_initiation_date": "20141006", "center_classification_date": "20141031", "termination_date": "20150630", "report_date": "20141112", "code_info": "Lot #: 20140718@4, discard date: 10/16/2014"}, {"country": "United States", "city": "Cary", "address_1": "3909 3 Oaks Rd", "reason_for_recall": "Cross Contamination With Other Products: Oral care solutions were manufactured by a third party supplier on equipment shared with non-pharmaceutical products", "address_2": "", "product_quantity": "945 cases", "code_info": "Product Code: 6060; Lots: 53057, EXP 12/7/2017; 57537, 59140, 60722, EXP 5/23/2017.", "center_classification_date": "20180209", "distribution_pattern": "Distributed Nationwide in the USA and Puerto Rico,  Canada, United Kingdom, Ireland, Netherlands, New Zealand", "state": "IL", "product_description": "Toothette Oral Care Perox-A- Mint solution, Oral Debriding Agent 8 fl oz/237 ml. Sage Products, Inc., 3909 Three Oaks Road, Cary, IL 60013. Product Code 6060 UPC (01)00618029800152", "report_date": "20180221", "classification": "Class II", "openfda": {}, "recalling_firm": "Sage Products Inc", "recall_number": "D-0366-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "77992", "termination_date": "20181213", "more_code_info": "", "recall_initiation_date": "20170822", "postal_code": "60013-1804", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; traZODone HCl Tablet, 50 mg may be potentially mislabeled as    AMANTADINE HCL, Tablet, 100 mg, NDC 00832011100, Pedigree: AD54475_1, EXP: 5/20/2014.", "address_2": "", "product_quantity": "2,000 Tablets", "code_info": "traZODone HCl, Tablet, 50 mg has the following code    Pedigree: AD54475_7, EXP: 5/20/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "traZODone HCl Tablet, 50 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 50111043303", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-593-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Little Rock", "state": "AR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78320", "recalling_firm": "SCA Pharmaceuticals, LLC", "address_1": "8821 Knoedl Ct", "address_2": "N/A", "postal_code": "72205-4600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the United States", "recall_number": "D-0060-2018", "product_description": "HYDROmorphone HCL 1 mg per mL in 0.9% Sodium Chloride 25 mL Fill in 30 mL single-dose syringe (Total Dose Hydromorphone 25 mg/25 mL)  Rx Only SCA Pharmaceuticals 8821 Knoedl Ct Little Rock, AR NDC 70004-0303-17", "product_quantity": "128 syringes", "reason_for_recall": "Lack Of Assurance Of Sterility.", "recall_initiation_date": "20171019", "center_classification_date": "20171102", "termination_date": "20190501", "report_date": "20171108", "code_info": "Lot: 20170808@52 BUD: 11/06/2017"}, {"status": "Terminated", "city": "Palm Harbor", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81810", "recalling_firm": "Promise Pharmacy, LLC", "address_1": "31818 Us Highway 19 N", "address_2": "N/A", "postal_code": "34684-3713", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0450-2019", "product_description": "Sermorelin/GHRP2/GHRP6, 9 mg/9 mg/9 mg injection, Rx Only, Promise Pharmacy Compounding Specialists 31818 US Hwy 19N, Palm Harbor, FL 34684", "product_quantity": "341 vials", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20181217", "center_classification_date": "20190208", "termination_date": "20210330", "report_date": "20190220", "code_info": "Lots: 07102018@3 BUD: 1/6/2019 08302018@9 BUD: 2/26/2019"}, {"status": "Terminated", "city": "Mesa", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83669", "recalling_firm": "First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy", "address_1": "6828 E Brown Rd Ste 101", "address_2": "N/A", "postal_code": "85207-3761", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0215-2020", "product_description": "S-E2/TEST CYP 0.4MG/1MG/MLMDV IN OIL INJECTION, 10 ml glass vial, Rx Only, Red Mountain Compounding Rx.", "product_quantity": "1x10 glass vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190812", "center_classification_date": "20191105", "termination_date": "20230413", "report_date": "20191113", "code_info": "Lot #:  S06262019DT@08, Exp 9/26/19;"}, {"status": "Terminated", "city": "Naperville", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69152", "recalling_firm": "Martin Avenue Pharmacy, Inc.", "address_1": "1247 Rickert Dr", "address_2": "N/A", "postal_code": "60540-1008", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0116-2015", "product_description": "PGE 20 mcg/mL injectable packaged in a clear glass injectable vial, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.", "product_quantity": "10 mL", "reason_for_recall": "Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.", "recall_initiation_date": "20140827", "center_classification_date": "20141029", "termination_date": "20180531", "report_date": "20141105", "code_info": "Lot Number: 08072014@35, Exp 11/5/2014; 08182014@18, Exp 11/16/2014", "more_code_info": ""}, {"status": "Terminated", "city": "Ocala", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75289", "recalling_firm": "Wells Pharmacy Network LLC", "address_1": "1210 SW 33rd Ave", "address_2": "N/A", "postal_code": "34474-2853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0410-2017", "product_description": "Trimix with Atropine Injectable 30 mg/3 mg/300 mcg/0.2 mg/mL, 10 mL vial, Compounded by Wells Pharmacy, Ocala, FL", "product_quantity": "3 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20160921", "center_classification_date": "20170104", "termination_date": "20210702", "report_date": "20170111", "code_info": "All lot codes of product prepared between 02/22/2016 and 09/14/2016, within expiry.     Known lot code: 07192016@8."}, {"status": "Terminated", "city": "Salisbury", "state": "MD", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "88523", "recalling_firm": "Jubilant Cadista Pharmaceuticals, Inc.", "address_1": "207 Kiley Dr", "address_2": "N/A", "postal_code": "21801-2249", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed nationwide.", "recall_number": "D-0784-2021", "product_description": "Donepezil HCL Tablets, USP, 5 mg, 90-count bottle, Rx only, Manufactured by: Jubilant Generics Ltd. India, Marketed by: Jubilant Cadista Pharmaceuticals Inc. Salisbury, MD 21801  NDC 59746-329-90", "product_quantity": "14,544 bottles", "reason_for_recall": "Subpotent", "recall_initiation_date": "20210820", "center_classification_date": "20210831", "termination_date": "20220405", "report_date": "20210908", "code_info": "Lot # DN120006A, exp. date 12/2021"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0870-2019", "product_description": "Dr. King's SafeCare Rx Aller-Detox: Indoor Pollution Control, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955240129, NDC 57955-2408-2", "product_quantity": "57 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lot: 080415F Exp. 08/18"}, {"country": "United States", "city": "Farmingdale", "address_1": "65 E Carmans Rd", "reason_for_recall": "Marketed without an Approved NDA/ANDA; product found to contain methasterone and dimethazine which are steroid and/or steroid-like drug ingredients, making it an unapproved new drug", "address_2": "", "product_quantity": "unknown", "code_info": "Lot numbers: C02R and F03Q", "center_classification_date": "20140305", "distribution_pattern": "Nationwide", "state": "NY", "product_description": "B-50 capsules, Healthy Life Chemistry By Purity First, packaged in 100 count bottles, Manufactured for: Purity First Health Products, Inc. dba Healthy Life Chemistry 51 Florida Street, Farmingdale, NY 11735", "report_date": "20140312", "classification": "Class I", "openfda": {}, "recalling_firm": "Mira Health Products Ltd.", "recall_number": "D-1149-2014", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "65772", "termination_date": "20140915", "more_code_info": "", "recall_initiation_date": "20130722", "postal_code": "11735-3834", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "69506", "recalling_firm": "Wockhardt Usa Inc.", "address_1": "20 Waterview Blvd., Suite 3", "address_2": "N/A", "postal_code": "07054", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-0304-2015", "product_description": "Wockhardt  Metoprolol Succinate, Extended-Release Tablets USP, 50 mg,  a)100-count HDPE bottle (NDC 64679-735-02), b) 4000-count pack (64679-735-08), Manufactured by: Wockhardt Limited, Mumbai, India   Distributed by Wockhardt USA LLC. 20 Waterview Blvd. Parsippany, NJ 07054 USA .", "product_quantity": "1,118,400 extended release tablets", "reason_for_recall": "Failed Dissolution Specifications: Product was out of specification (OOS) at the 12 month long term stability testing point.", "recall_initiation_date": "20140417", "center_classification_date": "20141218", "termination_date": "20150813", "report_date": "20141224", "code_info": "a) Lot # LN10392; Exp. 12/14  b) Lot # LN10360; Exp. 12/14"}, {"status": "Terminated", "city": "Peoria", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72241", "recalling_firm": "Kalman Health & Wellness, Inc. dba Essential Wellness Pharma", "address_1": "4625 N University St", "address_2": "N/A", "postal_code": "61614-5828", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-335-2016", "product_description": "TRIMIX #4 (27 mg-1.5 mg-50 mcg/mL) Injection, 5 mL vials, Rx only, Essential Wellness PHARMACY, 4625 N. University, Peoria, IL 61614.", "product_quantity": "1 vial", "reason_for_recall": "Lack of Assurance of Sterility:  A recall of all compounded sterile preparations within expiry is being initiated due to observations associated with poor sterile production practices resulting in a lack of sterility assurance for their finished drugs.", "recall_initiation_date": "20150903", "center_classification_date": "20151117", "termination_date": "20171229", "report_date": "20151125", "code_info": "Lot #: 070715, Exp 09/07/2015"}, {"status": "Ongoing", "city": "Flushing", "state": "NY", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "87712", "recalling_firm": "NSNY Distributor Inc", "address_1": "4570 192nd St", "address_2": "N/A", "postal_code": "11358-3438", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "USA Nationwide", "recall_number": "D-0642-2021", "product_description": "Ginseng Power 5000 capsule, 1- count per blister card, GS Natural Co, Los Angeles, CA 90010, UPC 0 40232 18144 3", "product_quantity": "399 capsules", "reason_for_recall": "Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/ or tadalafil", "recall_initiation_date": "20210408", "center_classification_date": "20210628", "report_date": "20210707", "code_info": "all lots"}, {"country": "United States", "city": "North Blenheim", "address_1": "119 Creamery Road", "reason_for_recall": "cGMP Deviations; products being recalled in response to a recall notice from the manufacturer, Wockhardt Limited, following a FDA inspection which noted inadequate investigation of market complaints, resulting in unsuccessful identification of root causes, and the investigation not being expanded to prevent repeat failure", "address_2": "", "product_quantity": "166 bottles", "code_info": "Lot BP20101301, Exp. Date  02/28/2016", "center_classification_date": "20150528", "distribution_pattern": "Indiana", "state": "NY", "product_description": "Captopril Tablets, USP, 50 mg, 30 Tablets, Rx Only, Dist. By: Wockhardt USA LLC, Parsippany, NJ 07054, Packaged By:  Blenheim Pharmacal Inc. North Blenheim, NY 12131, NDC 10544-175-30, MFG: 64679-904-02", "report_date": "20150603", "classification": "Class II", "openfda": {}, "recalling_firm": "Blenheim Pharmacal, Inc.", "recall_number": "D-1109-2015", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "71331", "termination_date": "20160115", "more_code_info": "", "recall_initiation_date": "20150522", "postal_code": "12131", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "73925", "recalling_firm": "Pharmedium Services, LLC", "address_1": "150 N Field Dr Ste 350", "address_2": "N/A", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-0092-2017", "product_description": "lidocaine HCl, 2%, 20 mg per mL (100 mg per 5 mL), 5 mL Total Volume in a syringe, Rx only, PharMEDium, Product code 2R3110.", "product_quantity": "499 syringes", "reason_for_recall": "Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.", "recall_initiation_date": "20150717", "center_classification_date": "20161012", "termination_date": "20170623", "report_date": "20161019", "code_info": "Lot Number: 15112122M, Exp between 07/15/15-10/12/15"}, {"status": "Terminated", "city": "Venice", "state": "FL", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "87828", "recalling_firm": "Scentsational Soaps & Candles Inc", "address_1": "730 Commerce Dr", "address_2": "N/A", "postal_code": "34292-1726", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "USA Nationwide", "recall_number": "D-0678-2021", "product_description": "Goose Creek Hand Sanitizer aloe Marshmallows, Anti-Bacterial Spray, 3.38 FL. OZ. (100 mL), Goose Creek www.GooseCreekCandle.com, 1498 S. Wallace Wilkinson Blvd., Liberty, KY 42539, UPC 8 18489 01331 8", "product_quantity": "1,296 bottles", "reason_for_recall": "Chemical contamination: product found to be contaminated with methanol (wood alcohol), benzene and acetaldehyde.", "recall_initiation_date": "20210427", "center_classification_date": "20210719", "termination_date": "20221202", "report_date": "20210728", "code_info": "Lot #: 20258", "more_code_info": ""}, {"status": "Ongoing", "city": "Brookhaven", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85781", "recalling_firm": "Amneal Pharmaceuticals of New York, LLC", "address_1": "50 Horseblock Rd", "address_2": "N/A", "postal_code": "11719-9509", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-1350-2020", "product_description": "amneal Metformin Hydrochloride Extended-Release Tablets, USP, Bulk, Distributed by: Amneal Pharmaceuticals LLC Bridgewater, NJ 08807   NDC 53746-0178-BULK", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level", "recall_initiation_date": "20200529", "center_classification_date": "20200625", "report_date": "20200701", "code_info": "HA01320A 1/31/2021  HA01420A 1/31/2021  HA06820A 1/31/2021  HB03620A 1/31/2021  HB03720A 1/31/2021  HB03820A 1/31/2021  HB03920A 1/31/2021  HB04020A 1/31/2021  HB04120A 1/31/2021  HB04220A 1/31/2021  HB04320A 2/28/2021  HB04420A 1/31/2021  HB04520A 2/28/2021  HB05020A 2/28/2021  HB05120A 2/28/2021  HB05220A 2/28/2021  HB05320A 2/28/2021  HB05420A 2/28/2021  HB05520A 2/28/2021  HB05620A 2/28/2021  HB07020A 2/28/2021  HB07120A 2/28/2021  HB07220A 2/28/2021  HB07320A 2/28/2021  HB07520A 2/28/2021  HB07620A 2/28/2021  HB07720A 2/28/2021  HB07820A 2/28/2021  HB07920A 2/28/2021  HB08020A 2/28/2021  HB08220A 2/28/2021  HF05519A 6/30/2020  HF05619A 6/30/2020  HF05719A 6/30/2020  HF05819A 6/30/2020  HF05919A 6/30/2020  HF06019A 6/30/2020  HF06119A 6/30/2020  HF06219A 6/30/2020  HF06319A 6/30/2020  HF07719A 6/30/2020  HF07819A 6/30/2020  HF07919A 6/30/2020  HF08019A 6/30/2020  HF08119A 6/30/2020  HF08219A 6/30/2020  HF08319A 6/30/2020  HF08419A 6/30/2020  HF08519A 6/30/2020  HF08619A 6/30/2020  HF10119A 6/30/2020  HF10219A 6/30/2020  HF10319A 6/30/2020  HF10419A 6/30/2020  HF10519A 6/30/2020  HF10619A 6/30/2020  HF10719A 6/30/2020  HF10819A 6/30/2020  HF10919A 6/30/2020  HF11019A 6/30/2020  HF11119A 6/30/2020  HG07219A 7/31/2020  HG07319A 7/31/2020  HG07419A 7/31/2020  HG07519A 7/31/2020  HG07619A 7/31/2020  HG07719A 7/31/2020  HG07819A 7/31/2020  HG07919A 7/31/2020  HG08019A 7/31/2020  HG08119A 7/31/2020  HH00619A 7/31/2020  HH00719A 7/31/2020  HH00819A 7/31/2020  HH00919A 7/31/2020  HH01019A 7/31/2020  HH01119A 8/31/2020  HH01219A 8/31/2020  HH01319A 8/31/2020  HH01419A 8/31/2020  HH01519A 8/31/2020  HH07319A 8/31/2020  HH07419A 8/31/2020  HH07519A 8/31/2020  HH07619A 8/31/2020  HH07719A 8/31/2020  HH07819A 8/31/2020  HH07919A 8/31/2020  HH08019A 8/31/2020  HH08119A 8/31/2020  HH08219A 8/31/2020  HH11119A 10/31/2020  HH11219A 10/31/2020  HH11319A 10/31/2020  HH11419A 10/31/2020  HH11519A 10/31/2020  HH11619A 10/31/2020  HH11719A 10/31/2020  HH11819A 10/31/2020  HH11919A 10/31/2020  HH12019A 10/31/2020  HH12119A 10/31/2020  HH12219A 10/31/2020  HH12319A 10/31/2020  HH12419A 10/31/2020  HH12519A 10/31/2020  HH12619A 10/31/2020  HH12719A 10/31/2020  HH12819A 10/31/2020  HH12919A 10/31/2020  HH13019A 10/31/2020  HL00119A 10/31/2020  HL00219A 11/30/2020  HL00319A 11/30/2020  HL00419A 11/30/2020  HL00519A 11/30/2020  HL00619A 11/30/2020  HL00719A 11/30/2020  HL00819A 11/30/2020  HL00919A 11/30/2020  HL01019A 11/30/2020"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: MEXILETINE HCL, Capsule, 200 mg may have potentially been mislabeled as the following drug:  ISOSORBIDE DINITRATE, Tablet, 10 mg, NDC 00781155601, Pedigree: AD25264_1, EXP: 5/3/2014.", "address_2": "", "product_quantity": "100 Capsules", "code_info": "MEXILETINE HCL, Capsule, 200 mg has the following codes: Pedigree: AD25264_7, EXP: 5/3/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "MEXILETINE HCL, Capsule, 200 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00093874001.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-856-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Monmouth Junction", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA091632"], "brand_name": ["HYDROCODONE POLISTIREX AND CHLORPHENIRAMINE POLISTIREX"], "generic_name": ["HYDROCODONE POLISTIREX AND CHLORPHENIRAMINE POLISTIREX"], "manufacturer_name": ["Cranbury Pharmaceuticals, LLC"], "product_ndc": ["27808-086"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CHLORPHENIRAMINE MALEATE", "HYDROCODONE BITARTRATE"], "rxcui": ["1087459"], "spl_id": ["6055d9e4-262f-4fd2-995f-37f17894eeab"], "spl_set_id": ["25f400d9-1d6e-4d38-8f0d-98d471eba73b"], "package_ndc": ["27808-086-02", "27808-086-01", "27808-086-03"], "is_original_packager": [true], "upc": ["0327808086013", "0327808086020"], "unii": ["V1Q0O9OJ9Z", "NO70W886KK"]}, "product_type": "Drugs", "event_id": "83346", "recalling_firm": "Tris Pharma Inc.", "address_1": "2033 US Highway 130", "address_2": "N/A", "postal_code": "08852-3003", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-1517-2019", "product_description": "Hydrocodone Polistirex and Chlorpheniramine Polistirex Extended-Release Suspension, (equivalent to 10 mg hydrocodone bitartrate and 8 mg chlorpheniramine maleate per 5 mL), 16 fl. oz. (473 mL) bottle, Rx only, Manufactured by: Tris Pharma, Inc., Monmouth Junction, NJ  08852, NDC 27808-086-02.", "product_quantity": "2,550 bottles", "reason_for_recall": "Superpotent Drug and Failed Stability Specifications: High out-of-specification results for the active ingredients, hydrocodone and chlorpheniramine, as well as high out-of-specification results for the preservatives.", "recall_initiation_date": "20190711", "center_classification_date": "20190724", "termination_date": "20211102", "report_date": "20190731", "code_info": "Lot#: 14079, Exp 10/2021"}, {"status": "Terminated", "city": "Brooklyn", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83136", "recalling_firm": "Infusion Options, Inc.", "address_1": "5924 13th Ave", "address_2": "N/A", "postal_code": "11219-4934", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "NY only", "recall_number": "D-1762-2019", "product_description": "Cytarabine 128 MG/250 ML D5W IVPB; Cytarabine 20 MG / 1 ML SQ SYRINGE  Cytarabine 70 MG QS 6 ML PF NS SYRINGE; Cytarabine 100 MG QS 3 ML PF NS SYRINGE, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190612", "center_classification_date": "20190815", "termination_date": "20250321", "report_date": "20190821", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71629", "recalling_firm": "Hospira Inc.", "address_1": "275 N Field Dr", "address_2": "N/A", "postal_code": "60045-2579", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "United States", "recall_number": "D-1240-2015", "product_description": "0.9% Sodium Chloride Injection USP, 50 mL ADD-Vantage Unit, Rx only, Manufactured by Hospira, Inc., Ausitn, TX 78728, NDC 00409-7101-68", "product_quantity": "314600 bags", "reason_for_recall": "Lack of assurance of sterility: Potential channel leaks near the threaded vial port.", "recall_initiation_date": "20150702", "center_classification_date": "20150715", "termination_date": "20161117", "report_date": "20150722", "code_info": "Lot #: 49-084-JT; 49-119-JT", "more_code_info": ""}, {"status": "Ongoing", "city": "W Hollywood", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95250", "recalling_firm": "PREQUEL SKIN", "address_1": "8560 W Sunset Blvd Ste 800", "address_2": "", "postal_code": "90069-2340", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Distributed nationwide in USA and on line", "recall_number": "D-0657-2024", "product_description": "BARRIER THERAPY SKIN PROTECTANT CREAM (1% colloidal oatmeal), 10 FL OZ/296 ML- tube, Distributed By: Prequel, LOS ANGELES, CA 90069. UPC 8 10129 11007 4", "product_quantity": "30,946 tubes", "reason_for_recall": "Microbial contamination of non-sterile Products -", "recall_initiation_date": "20240828", "center_classification_date": "20240909", "report_date": "20240918", "code_info": "Lot: X4054A, Exp: 2/2026; X4136A, X4137A, X4138A, Exp: 5/2026", "more_code_info": ""}, {"status": "Terminated", "city": "Allegan", "state": "MI", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "76443", "recalling_firm": "L. Perrigo Company", "address_1": "515 Eastern Ave", "address_2": "N/A", "postal_code": "49010-9070", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within United States", "recall_number": "D-0503-2017", "product_description": "Salicylic Acid Shampoo, 6%, 177 mL bottle, Rx only, Manufactured By Perrigo Yeruham, Israel, Distributed By Perrigo Allegan, MI 49010, NDC 45802-237-01,   UPC 3 45802-237-01 9.", "product_quantity": "10,656 units total for both products", "reason_for_recall": "Failed Impurities/Degradation Specifications: The API for these products had an out of specification result for an organic impurity.", "recall_initiation_date": "20170213", "center_classification_date": "20170301", "termination_date": "20170926", "report_date": "20170308", "code_info": "Lot #: 099534, Exp. 07/18; 099512 Exp. 06/18.", "more_code_info": ""}, {"status": "Terminated", "city": "Upper Darby", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83399", "recalling_firm": "Dercher Enterprises, Inc., DBA Gordon Laboratories", "address_1": "6801 Ludlow St", "address_2": "N/A", "postal_code": "19082-2408", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1528-2019", "product_description": "MONSEL'S (Ferric Subsulfate) Solution, 8 mL amber glass bottle, packaged as one dozen bottles with applicators per box, Rx only, Gordon Laboratories, Upper Darby, PA 19082, NDC 10481-0112-8.", "product_quantity": "277 boxes", "reason_for_recall": "Microbial Contamination of Non-Sterile Products and Superpotent Drug: FDA analysis revealed microbial contamination in addition to high out of specification results for iron content.", "recall_initiation_date": "20190719", "center_classification_date": "20190725", "termination_date": "20230814", "report_date": "20190731", "code_info": "Batch #: 579634, 579635, Exp 5/2020"}, {"country": "United States", "city": "Cary", "address_1": "3909 3 Oaks Rd", "reason_for_recall": "Cross Contamination With Other Products: Oral care solutions were manufactured by a third party supplier on equipment shared with non-pharmaceutical products", "address_2": "", "product_quantity": "2408 Cases", "code_info": "Product Code: 6602; Lots: 52005, EXP 09/12/2017; 52917, EXP 11/07/2017; 53327, EXP 12/05/2017; 54186, EXP 02/06/2018; 55327, EXP 04/17/2018; 56169, EXP 06/12/2018;  57385, EXP 08/29/2018; 58564, EXP 10/30/2018; 60205, EXP 11/27/2018; 61033, EXP 03/19/2019; 61443, EXP 04/09/2019.", "center_classification_date": "20180209", "distribution_pattern": "Distributed Nationwide in the USA and Puerto Rico,  Canada, United Kingdom, Ireland, Netherlands, New Zealand", "state": "IL", "product_description": "Toothette Oral Care Q Care & Suctioning System. Contains  1 Covered Yankauer, Suction Handle and Y-Connector, 2 Suction Toothbrush packages with Perox-A-Mint solution, 10 Suction Oral Swab packages with Perox-A-Mint solution, 4 Oropharyngeal Suction Catheter packages. Sage Products, Inc., 3909 Three Oaks Road, Cary, IL 60013. Product Code 6602 UPC 6 18029 84116 2", "report_date": "20180221", "classification": "Class II", "openfda": {}, "recalling_firm": "Sage Products Inc", "recall_number": "D-0389-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "77992", "termination_date": "20181213", "more_code_info": "", "recall_initiation_date": "20170822", "postal_code": "60013-1804", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Birmingham", "address_1": "6801 Cahaba Valley Rd Ste 116", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "7000 mL in Vials", "code_info": "a) Lot #: 160107-37, BUD: 07/5/16;  Lot #: 160303-67, BUD: 07/31/16.  b) Lot #: 160107-37, BUD: 07/5/16;  Lot #: 160303-67, BUD: 07/31/16.", "center_classification_date": "20160708", "distribution_pattern": "U.S. Nationwide, Japan, and New Zealand.", "state": "AL", "product_description": "LIPO W/LIDOCAINE #3 W/PRES. (BENZYL ETOH 2%) ASCORBIC ACID 50MG; B1-50MG;B2-5-P04-5MG;D3-30MG; B5-5MG;B6-5MG;CYANO B12-1MG; METHIONINE 12.5MG; INOSITOL-25MG; CHOLINE CL-25 MG; LIDOCAINE 10MG/ML, In a) 5 ML Vials and b) 10ML Vials, MEDAUS PHARMACY", "report_date": "20160720", "classification": "Class II", "openfda": {}, "recalling_firm": "Medaus, Inc.", "recall_number": "D-1201-2016", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "74466", "termination_date": "20170616", "more_code_info": "", "recall_initiation_date": "20160513", "postal_code": "35242-9609", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92707", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1041-2023", "product_description": "CARDIOPLEGIA SOLUTION, 24 mEq K, Maintenance 8:1 non-enriched, Low Potassium, IV Bag, Total Volume = 300 mL, RX only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC 72196-0215-1", "product_quantity": "104 bags", "reason_for_recall": "Lack of assurance of sterility. Validation data for decontamination cycles is lacking.", "recall_initiation_date": "20230714", "center_classification_date": "20230801", "termination_date": "20250328", "report_date": "20230809", "code_info": "Lot: 36-254125, Exp. 7/20/2023; 36-256034, Exp. 7/28/2023."}, {"status": "Terminated", "city": "Baltimore", "state": "MD", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "89268", "recalling_firm": "Lupin Pharmaceuticals Inc.", "address_1": "Harborplace Tower", "address_2": "111 S Calvert St Fl 21st", "postal_code": "21202-6174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0326-2022", "product_description": "Gatifloxacin Ophthalmic Solution, 0.5%, 2.5 mL bottle, Rx only, Manufactured by: Lupin Limited, Pithampur (M.P.) 454 775, INDIA, NDC 68180-435-01.", "product_quantity": "50,832 bottles", "reason_for_recall": "Failed Stability Specifications: Out-of-specification results observed in a water loss test that might affect the assay content and alter drug concentration.", "recall_initiation_date": "20211222", "center_classification_date": "20220104", "termination_date": "20220912", "report_date": "20220112", "code_info": "Lot #: H003037, exp. date May 2022; H100132, exp. date June 2022; H100847, exp. date October 2022"}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "13 mL total volume", "code_info": "All lots distributed between November 2014 and May 2015;    03032015@24, 6/1/2015; 03312015@79, 6/29/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Ascorbic Acid 1.25% Glutathione 1.25% DMSO 6.25%   Ophthalmic Solution, Sterile, Refrigerate, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1443-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "ISELIN", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA216436"], "brand_name": ["ATORVASTATIN CALCIUM"], "generic_name": ["ATORVASTATIN CALCIUM"], "manufacturer_name": ["Biocon Pharma Inc."], "product_ndc": ["70377-077", "70377-078", "70377-079", "70377-080"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ATORVASTATIN CALCIUM TRIHYDRATE"], "rxcui": ["259255", "617310", "617311", "617312"], "spl_id": ["72b8b3f5-4658-80af-655c-87ce7966a5e6"], "spl_set_id": ["5b839619-1805-c227-91bf-182f5b966ba4"], "package_ndc": ["70377-077-11", "70377-077-13", "70377-077-12", "70377-078-11", "70377-078-13", "70377-078-12", "70377-079-11", "70377-079-12", "70377-079-13", "70377-080-11", "70377-080-12", "70377-080-13"], "is_original_packager": [true], "upc": ["0370377080111"], "unii": ["48A5M73Z4Q"]}, "product_type": "Drugs", "event_id": "96496", "recalling_firm": "BIOCON PHARMA INC", "address_1": "485 HWY 1 (S)", "address_2": "", "postal_code": "08830", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "", "distribution_pattern": "U.S.A. nationwide", "recall_number": "D-0306-2025", "product_description": "Atorvastatin Calcium Tablets USP 40 mg, 1000-count bottle, Rx Only, Manufactured for: Biocon Pharma Inc., Iselin, NJ 08830-3009 USA, Manufactured by: Recipharm Pharmaservices PVT, Ltd Bengaluru, INDIA -562-123, NDC 70377-079-13", "product_quantity": "2184 bottles", "reason_for_recall": "Failed dissolution specifications: lower than specifications", "recall_initiation_date": "20250317", "center_classification_date": "20250328", "report_date": "20250409", "code_info": "Lot#: AVC24035, Exp 03/31/26", "more_code_info": ""}, {"status": "Terminated", "city": "North Chicago", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA020517"], "brand_name": ["LUPRON DEPOT"], "generic_name": ["LEUPROLIDE ACETATE"], "manufacturer_name": ["AbbVie Inc."], "product_ndc": ["0074-3346", "0074-3473", "0074-3683", "0074-3642"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "spl_id": ["98a4f293-ee7c-44d0-9a1e-9dc7faf8aaf8"], "spl_set_id": ["cbc8f94e-7330-4465-05ad-16d64493a5dd"], "package_ndc": ["0074-3473-03", "0074-3683-03", "0074-3642-03", "0074-3346-03"], "is_original_packager": [true], "upc": ["300743642032"]}, "product_type": "Drugs", "event_id": "67709", "recalling_firm": "AbbVie Inc", "address_1": "1 N Waukegan Rd", "address_2": "", "postal_code": "60064", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-1291-2014", "product_description": "Lupron Depot (Leuprolide Acetate for Depot Suspension) Single Dose Administration Kit with prefilled dual-chamber syringe, 7.5 mg for 1-month administration, Rx only, Manufactured for: AbbVie Inc., North Chicago, IL  60064; by: Takeda Pharmaceutical Company Limited, Osaka, Japan 540-8645; NDC 0074-3642-03, UPC 3 00743 64203 2.", "product_quantity": "2915 kits", "reason_for_recall": "Defective Delivery System: Some Lupron Depot Kits may containin a syringe with a potentially defective LuproLoc needle stick protection device.", "recall_initiation_date": "20140310", "center_classification_date": "20140429", "termination_date": "20160622", "report_date": "20140507", "code_info": "Lot #: 1012381, 1012383, Exp 08/22/16", "more_code_info": ""}, {"status": "Terminated", "city": "Sellersville", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "61871", "recalling_firm": "Teva Pharmaceuticals USA, Inc.", "address_1": "650 Cathill Rd", "address_2": "N/A", "postal_code": "18960-1512", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Ohio", "recall_number": "D-1409-2012", "product_description": "Metoprolol Tartrate Tablets USP 50 mg, 1000 count bottle, Rx only, Manufactured in india By: Emcure Pharmaceuticals LTD. Hinjwadi, Pune, India, Manufactured for TEVA Phamaceuticals USA, Sellersville, PA 18960, NDC 0093-0733-10", "product_quantity": "2,268 bottles", "reason_for_recall": "Tablet Thickness: Potential for some tablets not conforming to weight specifications (under and over weight)", "recall_initiation_date": "20120516", "center_classification_date": "20120705", "termination_date": "20130322", "report_date": "20120711", "code_info": "Lot #TE1Y261, Exp, 12/2013"}, {"status": "Ongoing", "city": "Aurangabad, Maharashtra State", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA077259"], "brand_name": ["TIMOLOL MALEATE"], "generic_name": ["TIMOLOL MALEATE"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "product_ndc": ["64980-513", "64980-514"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["TIMOLOL MALEATE"], "rxcui": ["1923428", "1992303"], "spl_id": ["7ef88352-6fe4-48a4-b72b-15419d3ed051"], "spl_set_id": ["2ed21930-1e05-46de-8acd-cb6f4798a7fa"], "package_ndc": ["64980-513-05", "64980-513-01", "64980-513-15", "64980-514-05", "64980-514-01", "64980-514-15"], "is_original_packager": [true], "upc": ["0364980513050", "0364980514057"], "unii": ["P8Y54F701R"]}, "product_type": "Drugs", "event_id": "96740", "recalling_firm": "FDC Limited", "address_1": "B-8 MIDC Industrial Area", "address_2": "Waluj District", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0403-2025", "product_description": "Timolol Maleate Ophthalmic Solution USP, 0.5%, Sterile, 10mL bottles, Rx only, Manufactured by: FDC Limited, Waluj, Aurangabad, Maharashtra, India, Distributed by: Rising Pharmaceuticals Inc, New Jersey, NDC 64980-514-01.", "product_quantity": "60428 bottles", "reason_for_recall": "Defective Container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle.", "recall_initiation_date": "20250418", "center_classification_date": "20250505", "report_date": "20250514", "code_info": "Lot #: 083I098, Exp. Date 08/31/2025", "more_code_info": ""}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83721", "recalling_firm": "Akorn, Inc.", "address_1": "1925 W Field Ct Ste 300", "address_2": "", "postal_code": "60045-4862", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide  within the United States and Puerto Rico", "recall_number": "D-1878-2019", "product_description": "Lidocaine Hydroclhoride Jelly USP, 2%, 30 mL tubes, Rx Only, Sterile, Manufactured by: Akorn, Inc., Lake Forest, IL 60045.  NDC 17478-711-30", "product_quantity": "10,543 tubes", "reason_for_recall": "cGMP Deviations:  firm reported finding metal particulate matter in the filling room near the tube feeder during the filling operation of the product. No particulates were identified in the product, but rather were identified on the filling line.", "recall_initiation_date": "20190917", "center_classification_date": "20190924", "termination_date": "20220801", "report_date": "20191002", "code_info": "Lot #: 9B21A, Exp. 1/2022", "more_code_info": ""}, {"status": "Terminated", "city": "New York", "state": "NY", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "93124", "recalling_firm": "Pfizer Inc.", "address_1": "235 East 42nd Street", "address_2": "", "postal_code": "10017-5703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US and Puerto Rico.  The products were not distributed to government accounts or foreign consignees.", "recall_number": "D-0100-2024", "product_description": "4.2% Sodium Bicarbonate Injection, USP 5 mEq/10 mL (0.5mEq/mL), Glass ABBOJECT Unit of Use Syringe, packaged as 1 vial and injector per carton, Rx only, Hospira Inc., Lake Forest, IL 60045, NDC 0409-5534-24", "product_quantity": "24,900 vials", "reason_for_recall": "Presence of Particulate Matter: identified as glass.", "recall_initiation_date": "20231002", "center_classification_date": "20231109", "termination_date": "20250214", "report_date": "20231115", "code_info": "Lot#: GJ5007, Exp. 8/1/2024", "more_code_info": ""}, {"status": "Terminated", "city": "Greer", "state": "SC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75415", "recalling_firm": "North American Rescue LLC.", "address_1": "35 Tedwall Ct", "address_2": "N/A", "postal_code": "29650-4791", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide, Australia & Switzerland", "recall_number": "D-0181-2017", "product_description": "Mini Resupply Trauma Kit - Product Code 85-0835, North American Rescue", "product_quantity": "unknown", "reason_for_recall": "Lack of Assurance of Sterility: Concerns with product sterility by the manufacturer of the eye wash irrigating solution.", "recall_initiation_date": "20160927", "center_classification_date": "20161208", "termination_date": "20170309", "report_date": "20161214", "code_info": "Kit Part # 85-0835 - Kit Lot # 85-0835061016, 85-0835052416, 85-0835051116, 85-0835050216, 85-0835042916, 85-0835072616, 85-0835072016"}, {"status": "Terminated", "city": "Waltham", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85228", "recalling_firm": "Fresenius Medical Care Holdings, Inc.", "address_1": "920 Winter St Bld 950", "address_2": "", "postal_code": "02451-1521", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed throughout the United States.", "recall_number": "D-1064-2020", "product_description": "Sodium Chloride 0.9% Injection, USP, 1000 mL bags, Rx only, Manufactured by: Fresenius Medical Care North America, Waltham, MA 02451", "product_quantity": "32,592 bags", "reason_for_recall": "CGMP Deviation: Chemical indicators were not positioned properly during sterilization process.", "recall_initiation_date": "20200305", "center_classification_date": "20200326", "termination_date": "20230203", "report_date": "20200325", "code_info": "Lot #: 19EG02012, 19EG02019, Exp. Date 05/2020; 19DG02050, Exp. Date 04/2020", "more_code_info": ""}, {"status": "Ongoing", "city": "Melville", "state": "NY", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "96290", "recalling_firm": "Ascent Consumer Products Inc.", "address_1": "105 Baylis Rd", "address_2": "N/A", "postal_code": "11747-3833", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the US.", "recall_number": "D-0299-2025", "product_description": "SinuCleanse Soft Tip Squeeze Bottle Nasal Wash System (sodium bicarbonate USP 700 mg and sodium chloride USP 2300 mg), 30-count All Natural USP Grade Saline Packets and 1 Soft tip Squeeze Bottle, Net WT 0.1OZ (3g) each, Distributed by Ascent Consumer Products Inc., Melville, NY 11747, UPC 6 46011 00104 1", "product_quantity": "4,176 cartons", "reason_for_recall": "Microbial Contamination of Non-Sterile Products: Bacterial contamination with Staphylococcus aureus", "recall_initiation_date": "20250128", "center_classification_date": "20250325", "report_date": "20250402", "code_info": "Lot# 024122661Al, Exp Date 12/2027"}, {"status": "Terminated", "city": "Camarillo", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89712", "recalling_firm": "Golden State Medical Supply Inc.", "address_1": "5187 Camino Ruiz", "address_2": "N/A", "postal_code": "93012-8601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed to 1 wholesaler/distributor", "recall_number": "D-0654-2022", "product_description": "Alprazolam Tablets, USP 1mg, 180-count bottles, Rx only, Manufactured by ULTRAlab Laboratories, Inc., NY; Packaged by GSMS, Inc., CA NDC 60429-504-18.", "product_quantity": "401 bottles", "reason_for_recall": "CGMP Deviation: Potential cross-contamination with other drug substance during the manufacturing process.", "recall_initiation_date": "20220302", "center_classification_date": "20220315", "termination_date": "20220913", "report_date": "20220323", "code_info": "Lot #: GS027852, Expiry: 06/2022."}, {"status": "Terminated", "city": "Elizabeth", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "73474", "recalling_firm": "Actavis Elizabeth LLC", "address_1": "200 Elmora Ave", "address_2": "N/A", "postal_code": "07202-1106", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US: Nationwide", "recall_number": "D-0815-2016", "product_description": "Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Tablets, 30 mg, 100 ct. bottle, Rx Only.  Manufactured by: Actavis Elizabeth LLC, Elmora Avenue, Elizabeth, NJ 07207. Distributed by: Actavis, Inc., 80 Columbia Road, Bldg B, Morristown, NJ 07960. NDC: 45963-749-11.", "product_quantity": "182,378 Bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications: Out of specification for impurities.", "recall_initiation_date": "20160216", "center_classification_date": "20160407", "termination_date": "20170922", "report_date": "20160413", "code_info": "Lot #: 1879E141, Expiry 02/16; Lot #: 1880E141, Expiry: 02/16; Lot #: 5034M142; Expiry: 5/16; Lot #: 0422A151, Expiry: 7/16; Lot #: 0423A151, Expiry: 7/16; Lot #: 1053C151, Expiry: 8/16; Lot #: 1054C151, Expiry: 8/16; Lot #: 2197E152, Expiry: 11/16; Lot #: 2198E151, Expiry: 12/16; Lot #: 2662F151, Expiry: 12/16; Lot #: 2672F152, Expiry: 3/17; Lot #: 3121G152, Expiry: 3/17; Lot #: 3798J151, Expiry: 4/17; Lot #: 5104M151, Expiry: 5/17.", "more_code_info": ""}, {"status": "Terminated", "city": "Ferndale", "state": "WA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "67723", "recalling_firm": "Terra-Medica Inc.", "address_1": "1465 Slater Rd", "address_2": "N/A", "postal_code": "98248-8919", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Products were distributed US Nationwide, to Canada, to Philippines, and through internet sales.", "recall_number": "D-1212-2014", "product_description": "Pleo Stolo DROPS 6X, 10ml Bottle;  Homeopathic Anti-Inflammatory Medicine, OTC Only.  Made in Germany for: SANUM USA Copr, 1456 Slater Road, Ferndale, WA 98248 by Sanum-Kehlbeck GmbH & Co. KG. NDC: 49807-0011-1.", "product_quantity": "428 bottles", "reason_for_recall": "Penicillin Cross Contamination", "recall_initiation_date": "20140303", "center_classification_date": "20140407", "termination_date": "20140730", "report_date": "20140416", "code_info": "Batch # 08060; EXP: May 2015; Batch # 07119, EXP: August 2014; Batch # 03043, EXP: May 2018."}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA210221"], "brand_name": ["CEPHALEXIN"], "generic_name": ["CEPHALEXIN"], "manufacturer_name": ["Ascend Laboratories, LLC"], "product_ndc": ["67877-544", "67877-545"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CEPHALEXIN"], "rxcui": ["309110", "309113"], "spl_id": ["84f07b4a-a15e-41cb-af85-e110c5cf342e"], "spl_set_id": ["bb28751c-bd1b-4e7f-8271-a14c1b4314e3"], "package_ndc": ["67877-544-88", "67877-544-68", "67877-545-88", "67877-545-68"], "is_original_packager": [true], "unii": ["OBN7UDS42Y"]}, "product_type": "Drugs", "event_id": "87032", "recalling_firm": "Ascend Laboratories LLC", "address_1": "339 Jefferson Rd Ste 101", "address_2": "N/A", "postal_code": "07054-3707", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0179-2021", "product_description": "Ascend Laboratories, llc Cephalexin for Oral Suspension, USP 250 mg per 5 mL 200 ml (when mixed) Rx Only Manufactured by: Alkem Laboratories, Ltd, Mumbai -400 013 INDIA Distributed by: Ascend Laboratories, LLC Parsippany, NJ 07054 NDC 67877-545-68", "product_quantity": "9,524 bottles", "reason_for_recall": "Failed Impurity/Degradation Specifications", "recall_initiation_date": "20201217", "center_classification_date": "20201230", "termination_date": "20230503", "report_date": "20210106", "code_info": "20141680, 20141681, 20141759"}, {"status": "Terminated", "city": "Hauppauge", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81458", "recalling_firm": "Sciegen Pharmaceuticals Inc", "address_1": "89 Arkay Dr", "address_2": "N/A", "postal_code": "11788-3727", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0267-2019", "product_description": "Westminister Irbesartan Tablets, USP, 75 mg (a) 30-count bottle (NDC 69367-119-01), (b) 90-count bottle (NDC 69367-119-03), Rx Only, Manufactured by ScieGen Pharmaceuticals Inc Hauppauge, NY 11755   Manufactured for Westminister Pharmaceuticals LLC Olive Branch, MS 20854 Made in the USA", "product_quantity": "2,977 HDPE bottles", "reason_for_recall": "CGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-nitrosodimethylamine (NDEA) in product.", "recall_initiation_date": "20181029", "center_classification_date": "20181120", "termination_date": "20230925", "report_date": "20181128", "code_info": "69367-119-01 Irbesartan 75mg Tablets, 30 count bottle B160002A Sep-19     69367-119-03 Irbesartan 75mg Tablets, 90 count bottle B160002B Sep-19", "more_code_info": ""}, {"status": "Terminated", "city": "Allentown", "state": "PA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "70148", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "6580 Snowdrift Rd Ste 100", "address_2": "N/A", "postal_code": "18106-9331", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide", "recall_number": "D-450-2015", "product_description": "Sinai Hospital (MD) TPN Neonatal Day 1 Bag, Trophamine 10 g, Dextrose 25 g, Additives: Calcium Gluconate 1500 mg, compound vol: 250 ml, sterile injectable, Rx only, compounded drug, IV infusion bag packaged in a corrugated box, each container is lined with a polystyrene insert; CAPS, Allentown, PA.", "product_quantity": "4 bags", "reason_for_recall": "Non-Sterility: Out of specification results for the sterility test for microbial contamination.", "recall_initiation_date": "20141217", "center_classification_date": "20150408", "termination_date": "20150819", "report_date": "20150415", "code_info": "lot number 37-74693, Made on 15 DEC 2014, EXP 24 DEC 2014, CAPS Rx: 37-74693-0-4-R, Disp ID: 37-1124640"}, {"country": "United States", "city": "Houston", "address_1": "9265 Kirby Dr", "reason_for_recall": "Stability Data Does Not Support Expiry: lots do not have stability that supports the use of the container system.", "address_2": "", "product_quantity": "550 syringes", "code_info": "Lot: 4/20/17 0307 265-86361S, BUD 6/19/17; 4/26/17 0732 265-86361S, BUD 6/25/17; 4/28/17 0215 265-86361S, BUD 6/27/17; 5/2/17 0310 248-86361S, BUD 7/1/17; 5/4/17 1422 248-86361S, BUD 7/3/17; 5/12/17 0841 248-86361S, BUD 7/11/17; 5/18/17 0206 250-86361S, BUD 7/17/17", "center_classification_date": "20171220", "distribution_pattern": "Nationwide in the USA to hospitals and medical facilities.", "state": "TX", "product_description": "NitroGlycerin (2 mg/10 mL in 5% Dextrose Inj, USP QS 10mL (200 mcg per mL), 10 mL Sterile single dose syringe, packaged in 5 x 5 (TWENTY FIVE) syringes per box, Rx only, Advanced Pharma, 9265 Kirby Dr., Houston, TX  77054, NDC 15082-863-61.", "report_date": "20171227", "classification": "Class II", "openfda": {}, "recalling_firm": "Advanced Pharma Inc.", "recall_number": "D-0119-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "77503", "termination_date": "20190403", "more_code_info": "", "recall_initiation_date": "20170609", "postal_code": "77054-2520", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0152-2019", "product_description": "Epinepherine 1 mg/1 mL 3 mL Injectable Pharm D Solutions, Houston, Texas ---- NDC 69699-0109-03", "product_quantity": "945 syringes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lots: 07272018:17 Discard by: 9/25/2018; 08292018:74 Discard by: 10/28/2018"}, {"status": "Terminated", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "75030", "recalling_firm": "Amerisource Health Services", "address_1": "2550 John Glenn Ave Ste A", "address_2": "N/A", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-1501-2016", "product_description": "buPROPion Hydrochloride Extended-Release Tablets, USP (XL), 300mg, 500-count bottle, Rx only, Manufactured by: Cadila Healthcare Ltd., Ahmedabad, India For BluePoint Laboratories, NDC 68001-264-03", "product_quantity": "2626 bottles", "reason_for_recall": "Failed dissolution specifications - the out of specification result for dissolution was identified during 3 month stability testing.", "recall_initiation_date": "20160804", "center_classification_date": "20160915", "termination_date": "20170717", "report_date": "20160921", "code_info": "Lot #: MS1509, Exp 12/17", "more_code_info": ""}, {"status": "Terminated", "city": "Largo", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69250", "recalling_firm": "VistaPharm, Inc.", "address_1": "7265 Ulmerton Rd", "address_2": "", "postal_code": "33771-4809", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide, including Puerto Rico", "recall_number": "D-0010-2015", "product_description": "METOCLOPRAMIDE ORAL SOLUTION, USP 5 mg/5 mL, (present as the hydrochloride), 10 mL cups, Rx only. Manufactured by VistaPharm Inc., Largo, FL 33771. NDC 66689-031-01.", "product_quantity": "322,650 Cups", "reason_for_recall": "Defective Container: Product leaks when inverted.", "recall_initiation_date": "20140813", "center_classification_date": "20141009", "termination_date": "20150224", "report_date": "20141015", "code_info": "Lot #: 283700, Expiry: 11/14; Lot #: 291400, Expiry: 01/15; and Lot #: 303500, Expiry: 04/15.", "more_code_info": ""}, {"status": "Terminated", "city": "Boca Raton", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78553", "recalling_firm": "KRS Global Biotechnology, Inc", "address_1": "791 Park of Commerce Blvd Ste 600", "address_2": "N/A", "postal_code": "33487-3633", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA, Bermuda, and New Zealand", "recall_number": "D-0194-2018", "product_description": "Sermorelin, 3 mg/ GHRP6, 1.8 mg/ GHRP2, 1.8 mg/mL in 3 mL Cartridge, For SC Use, Rx Only, KRS Global Biotechnology, 791 Park of Commerce Blvd, Boca Raton, FL 33487.", "product_quantity": "80 cartridges", "reason_for_recall": "Labeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product.", "recall_initiation_date": "20171116", "center_classification_date": "20180108", "termination_date": "20200511", "report_date": "20180117", "code_info": "Lot: 10122017@8 BUD: 2/9/2018", "more_code_info": ""}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0773-2019", "product_description": "Dr. King's SafeCare Rx CS-Brain, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955021223, NDC 57955-0222-2", "product_quantity": "37 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 022616C Exp. 02/19; 122216E Exp. 12/19"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0775-2020", "product_description": "TRIMIX -A  (UA) 30MG/1MG/5 MCG/ML INJ in 1 mL vial  Assurance Infusion (713) 533-8800", "product_quantity": "10 vials", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 07082019@31 Exp. 01/04/2020", "more_code_info": ""}, {"status": "Terminated", "city": "Windsor", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93456", "recalling_firm": "SCA Pharmaceuticals, LLC", "address_1": "755 Rainbow Rd Ste B", "address_2": "N/A", "postal_code": "06095-1024", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0403-2024", "product_description": "fentaNYL 2,500 mcg/50 mL in 0.9 % Sodium Chloride Injection (Concentration = 50 mcg/mL) 50 mL Single Dose Syringe, Rx Only, SCA Pharmaceuticals, 755 Rainbow Rd. Windsor, CT 06095,  NDC 70004-0202-22, Bar code 70004020022,", "product_quantity": "500 syringes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20231109", "center_classification_date": "20240322", "termination_date": "20240827", "report_date": "20240403", "code_info": "Lot #: 1223048959, Exp 12/11/23; 1223049009, Exp 12/12/23; 1223049170, Exp 12/20/23; 1223049245, Exp 12/22/23", "more_code_info": ""}, {"status": "Terminated", "city": "Port Charlotte", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85404", "recalling_firm": "The Medicine Shoppe Pharmacy", "address_1": "3524b Tamiami Trl", "address_2": "", "postal_code": "33952-8100", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Florida", "recall_number": "D-1200-2020", "product_description": "Bi-Est 1:1/Progest/DHEA 1/40/5 mg/mL Cream 30 mL jar, Rx, The Medicine Shoppe Pharmacy, Port Charlotte, FL", "product_quantity": "1 jar", "reason_for_recall": "Lack of Processing Control", "recall_initiation_date": "20200406", "center_classification_date": "20200410", "termination_date": "20221213", "report_date": "20200422", "code_info": "Lot: 45146 Discard by: 8/30/2020", "more_code_info": ""}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-866-2015", "product_description": "Procarbazine HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "5115 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "St Petersburg", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65125", "recalling_firm": "THE COMPOUNDING SHOP, INC.", "address_1": "4000 Park St N", "address_2": "N/A", "postal_code": "33709-4034", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Florida, California, Minnesota, and Maine", "recall_number": "D-554-2013", "product_description": "Dexpanthenol 200 mg/mL Injectable, 100 mL vial, compounded by The Compounding Shop, St. Petersburg, FL", "product_quantity": "2 vials of 100mL", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes", "recall_initiation_date": "20130502", "center_classification_date": "20130604", "termination_date": "20240930", "report_date": "20130612", "code_info": "All Lots"}, {"status": "Terminated", "city": "Pithampur", "state": "N/A", "country": "India", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "77323", "recalling_firm": "Lupin Limited (Unit 1)", "address_1": "Unit 1, Plot 2, SEZ, Phase II,", "address_2": "Misc Zone Apparel Park, Dist. Dhar", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1093-2017", "product_description": "Mibelas 24 Fe (Norethindrone acetate and Ethinyl estradiol 1 mg/0.02 mg chewable and ferrous Fumarate 75 mg) Tablets, wallet of 28 tablets (NDC 68180-911-11), Carton of 3 wallets (NDC 68180-911-13), Rx Only, Manufactured by: Lupin Limited, India, Distributed by Lupin Pharmaceuticals, Inc., Baltimore, MD, 21202", "product_quantity": "24,652 tablets", "reason_for_recall": "Contraceptive Tablets Out of Sequence- First 4 pills of the packet are brown, instead of the last four pills and the expiry/lot was not printed on the package.", "recall_initiation_date": "20170516", "center_classification_date": "20170815", "termination_date": "20190530", "report_date": "20170823", "code_info": "Batch Number L600518; Exp. 05/18"}, {"status": "Ongoing", "city": "Northbrook", "state": "IL", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["NDA050708"], "brand_name": ["PROGRAF"], "generic_name": ["TACROLIMUS"], "manufacturer_name": ["Astellas Pharma US, Inc."], "product_ndc": ["0469-0607", "0469-0617", "0469-0657", "0469-3016", "0469-1230", "0469-1330"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["TACROLIMUS"], "rxcui": ["108513", "108514", "108515", "198377", "198378", "198379", "261134", "313190", "2052605", "2052609", "2052703", "2052704"], "spl_id": ["e9157663-1515-4ba3-83b5-1622cf6f0f99"], "spl_set_id": ["7f667de1-9dfa-4bd6-8ba0-15ee2d78873b"], "package_ndc": ["0469-0607-73", "0469-0617-73", "0469-0617-11", "0469-0657-73", "0469-0657-11", "0469-3016-01", "0469-1230-50", "0469-1330-50"], "is_original_packager": [true], "upc": ["0304690607731", "0304690657736", "0304691230501", "0304691330508", "0304690617730", "0304693016011"], "unii": ["WM0HAQ4WNM"]}, "product_type": "Drugs", "event_id": "96008", "recalling_firm": "Astellas Pharma US Inc.", "address_1": "2375 Waterview Dr", "address_2": "", "postal_code": "60062-6145", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0211-2025", "product_description": "Prograf (tacrolimus) capsules, USP, 0.5 mg, 100-count bottle, Rx Only, Product of Japan, Distributed by: Astellas Pharma US, Inc., Northbrook, IL 60062, NDC 0469-0607-73.", "product_quantity": "14,340 100-count bottles", "reason_for_recall": "Failed Tablet/Capsule Specifications: Bottles shipped to the USA may contain empty capsules", "recall_initiation_date": "20241223", "center_classification_date": "20250129", "report_date": "20250205", "code_info": "Lot# 0E3353D, Exp 03/31/2026", "more_code_info": ""}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "73925", "recalling_firm": "Pharmedium Services, LLC", "address_1": "150 N Field Dr Ste 350", "address_2": "N/A", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-0032-2017", "product_description": "Fentanyl Citrate 16.67 mcg per mL and Bupivacaine HCl 0.1667% in 0.9% Sodium Chloride, Total Dose 25.005 mcg/1.5 mL Fentanyl Citrate, Content Volume 1.5 mL in 3 mL BD Syringe, Intended for Epidural Use, Rx only, PharMEDium, Product code 2T6228.", "product_quantity": "210 syringes", "reason_for_recall": "Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.", "recall_initiation_date": "20150717", "center_classification_date": "20161012", "termination_date": "20170623", "report_date": "20161019", "code_info": "Lot Numbers: 151000045M, 15127040M, 15133026M, 15141029M, 151930078M, 15132103M, Exp between 07/15/15-10/12/15"}, {"status": "Terminated", "city": "Davie", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "74874", "recalling_firm": "Pharmatech LLC", "address_1": "4131 Sw 47th Ave", "address_2": "Suite 1403", "postal_code": "33314-4026", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1520-2016", "product_description": "Sennazon (sennosides) Syrup, 8.8 mg, 8 fl. oz. (237 mL) bottle, Mfd. for: Bayshore Pharmaceuticals, Tampla, FL  33619, NDC 76518-100-08.", "product_quantity": "1,008 bottles", "reason_for_recall": "CGMP Deviations: Recall initiated as a precautionary measure due to a potential risk of product contamination with the bacteria B. cepacia.", "recall_initiation_date": "20160808", "center_classification_date": "20160927", "termination_date": "20240923", "report_date": "20161005", "code_info": "Lot #: 20391519, Exp 11/17"}, {"status": "Terminated", "city": "West Columbia", "state": "SC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90211", "recalling_firm": "Nephron Sterile Compounding Center LLC", "address_1": "4500 12th Street Ext", "address_2": "N/A", "postal_code": "29172-3025", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0963-2022", "product_description": "Neostigmine Methylsulfate Injection, USP, 5 mg/5 mL (1 mg/mL), Preservative Free, 5 mL Pre-Filled Syringe, 5 x 5 mL Pre-Filled Syringes, 6 x 5 Syringe Carton, Rx Only Nephron 503B outsourcing facility 4500 12th St. Extension West Columbia, SC 29172 NDC: 69374-902-05", "product_quantity": "64450 syringes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20220518", "center_classification_date": "20220527", "termination_date": "20240823", "report_date": "20220608", "code_info": "Lots: NE2001A, Exp. 6/30/2022; NE2009B, Exp. 8/27/2022"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "47 units", "code_info": "Rx #'s:  0389833    0394741          0392912    0388244          0397159    0399176      0388244    0405177    0409379    0392912      0397159    0377235    0408837    0402247    0388244      0397159        0403342    0404418    0388244            0393276    0393276    0351537      0393276    0351537    0393276            0390499", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "GLUTATHIONE INHALATION  30MG/ML SOLUTION 120 ML, 60 ML; GLUTATHIONE P.F. 200MG/ML   INJECTABLE\t10 ML, 100 ML, 14 ML, 150 ML, 175 ML, 20 ML, 30 ML, 300 ML, 40 ML, 40 MLS, 50 ML, 58 MLS, 70 ML;\t  GLUTATHIONE P.F. 50MG/ML (500MG/10ML) INJECTABLE 100 ML, 150 ML, 20 ML, 40 ML,  60 ML; GLUTATHIONE-FFC  100MG/ML   INJECTABLE 20 ML (21 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1529-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Ocala", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75289", "recalling_firm": "Wells Pharmacy Network LLC", "address_1": "1210 SW 33rd Ave", "address_2": "N/A", "postal_code": "34474-2853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0348-2017", "product_description": "Chorionic Gonadotropin, Lyophilized, 5,000 unit Injectable Kit, Compounded by Wells Pharmacy, Ocala, FL", "product_quantity": "5277 kits (number of vials per kit vary by prescription)", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20160921", "center_classification_date": "20170104", "termination_date": "20210702", "report_date": "20170111", "code_info": "All lot codes of product prepared between 02/22/2016 and 09/14/2016, within expiry.     Known kit lot code: 04142016@75, 04252016@52, 05042016@143, 05042016@158, 06092016@169, 06242016@158, 08022016@154, 08112016@56, 08252016@82, 09082016@41.  Known vial lot code: 04062016@7, 04182016@49, 04292016@80, 04282016@43, 06012016@44, 06152016@57, 07132016@68, 08042016@35, 08192016@45, 08242016@33"}]